Home   Distributors   Careers   Contact

 

• State-of-the-art NOVOLIMUS™ eluting scaffold system
• Next generation in scaffold technology

learn more

Desolve | Novolimus Eluting Bioresorbable Coronary Scaffold System

• Eliminates the need for a primer coating
• Achieves a bare metal surface within 6–9 months
• Superior efficacy and excellent clinical safety

stent

Desyne BD | Novolimus Eluting Coronary Stent System

• Improved performance
• Superior clinical efficacy and safety

learn more

The State of the Art Drug Eluting Stent

Unique Drug Agent Novolimus

Advanced Drug Coating/Polymer Technology
• Lowest polymer coating load2
• Reduced risk of adverse clinical events3
• Reliable performance with lower drug dose

Unique Drug Agent Novolimus

• Proprietary drug facilitates superior clinical efficacy5
• Established safety and performance
• Clinically proven 'olimus' drug family

About Elixir

Innovating Vascular Restoration™

Leading the Way to Next Generation DES Platforms

Elixir Medical Corporation, a privately held company headquartered in Sunnyvale, CA, specializes in developing products that combine state-of-the-art technology with advanced pharmaceuticals to provide innovative treatment solutions to patients worldwide. Learn More...

 

In the News

Elixir Medical at TCT 2015

Pre-Register for the Symposium

Transforming PCI

*MRVD 3.75 – 4.00mm

^J. Ormiston el al, An independent bench comparison of two bioresorbable drug-eluting coronary scaffolds (Absorb and DESolve) with a durable metallic drug-eluting stent (ML8/Xpedition), EuroIntervention 2015; 10-online publish-ahead-of-print February 2015.

‡ Not to exceed .5mm beyond scaffold diameter.

Elixir, Innovation for life and DESolve are registered trademarks of Elixir. DESolve and DESolve XL are CE mark approved; not available for sale in the US.

DESolveCx and Amity are not available for sale: International use only.

The MedTech Strategist| Vol 2, Issue 12

Elixir Medical’s Contrarian Play in Cardiology: Go Bioresorbable or Go Home

Elixir Medical CEO Speaks on DESolve Platform

PCRTV - Elixir Medical - Motasim Sirhan

By viewing this video, you acknowledge that you are an international healthcare provider. DESolve is CE Mark approved. Not for sale in the U.S. PMN 293

 

 

Press Releases